The present invention relates to compositions comprising Torasemide Trimetazidine Mexiletine Ifenprodil Moxifloxacin or Bromocriptine or a salt prodrug derivative or sustained releaseformulation thereof and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid ß toxicity. More specifically the present invention relates to novel combinatorial therapies of Multiple Sclerosis Alzheimer's disease Alzheimer's disease related disorders Amyotrophic Lateral ...

Prolonged-release diuretic compositions containing torasemide as active ingredient. The compositions of the invention are useful to be able to avoid the troublesome urinary urgencies caused by conventional immediate- release compositions.

The present invention relates to the alleviation or treatment of one or more symptons caused by one or more conditions or diseases selected from the group consisting of dilated cardiomyopathy, acquired or naturally occurring valvular disease, hypertrophic cardiomyopathy, hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy and unclassified cardiomyopathy and combinations thereof. The present invention further relates to a kit and a method for alleviating or treating said symptoms....

A composition for the alleviation or treatment of one or more symptoms caused by one or more conditions or diseases selected from the group consisting of dilated cardiomyopathy, acquired or naturally occurring valvular disease, hypertrophic cardiomyopathy, hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy and unclassified cardiomyopathy and combinations thereof. Also disclosed is a kit and a method for alleviating or treating the symptoms.

A composition for the alleviation or treatment of one or more symptoms caused by one or more conditions or diseases selected from the group consisting of dilated cardiomyopathy acquired or naturally occurring valvular disease hypertrophic cardiomyopathy hypertrophic obstructive cardiomyopathy restrictive cardiomyopathy and unclassified cardiomyopathy and combinations thereof. Also disclosed is a kit and a method for alleviating or treating the symptoms.